|
|
Volumn 5, Issue 4, 1997, Pages 639-640
|
|
Lamivudine
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BC 189;
BCH 790;
LAMIVUDINE;
NGPB 21;
UNCLASSIFIED DRUG;
ZIDOVUDINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ANIMAL CELL;
ANIMAL EXPERIMENT;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
RAT;
SHORT SURVEY;
ANTIBIOTIC RESISTANCE;
AREA UNDER THE CURVE;
ARTICLE;
BIOAVAILABILITY;
DRUG COMBINATION;
DRUG EFFECT;
FOOD AND DRUG ADMINISTRATION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
SYNTHESIS;
UNITED STATES;
ANIMALIA;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
ADMINISTRATION, ORAL;
ANTI-HIV AGENTS;
AREA UNDER CURVE;
BIOLOGICAL AVAILABILITY;
DRUG RESISTANCE, MICROBIAL;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HIV-1;
HUMANS;
LAMIVUDINE;
REVERSE TRANSCRIPTASE INHIBITORS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
ZIDOVUDINE;
|
|
EID: 0031111401
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(97)00002-3 Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
